Will Obama's freeze chill science?

When he addresses the nation tonight (27th January), US President Obama is expected to call for a three-year freeze on federal spending for any programs not dealing with the military or homeland defense. But with the budget boosts for federal science agencies provided by 2009's American Recovery and Reinvestment Act drying up in 2011, science advocates are concerned that Obama's funding freeze may spell the steep budgetary drop-off in the next fiscal year that many dread.Image: US Senate "Certa

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
When he addresses the nation tonight (27th January), US President Obama is expected to call for a three-year freeze on federal spending for any programs not dealing with the military or homeland defense. But with the budget boosts for federal science agencies provided by 2009's American Recovery and Reinvestment Act drying up in 2011, science advocates are concerned that Obama's funding freeze may spell the steep budgetary drop-off in the next fiscal year that many dread.
Image: US Senate
"Certainly it does concern us," Kerry Peluso, associate vice president for research administration at Emory University in Atlanta, told __The Scientist__. "We want to see our researchers continue to be able to do their research." Though the announcement is not yet official, the White House has released some details of the proposed freeze in the run up to Obama's State of the Union address tonight and the release of his FY2011 budget proposal, which is slated for Monday (1st February). "The three-year freeze over the course of 10 years will save on the order of $250 billion," said press secretary Robert Gibbs at a White House linkurl:press briefing;http://www.whitehouse.gov/the-press-office/briefing-white-house-press-secretary-robert-gibbs-12610 yesterday. In an linkurl:entry;http://www.whitehouse.gov/blog/2010/01/26/putting-hatchets-vs-scapels-debate-about-budget-freeze-ice posted yesterday on The White House Blog, Vice President Joe Biden's chief economist and economic policy adviser Jared Bernstein said that Obama's freeze would be more like surgery and less like a hatchet job. "...the entire theory of the President's proposed freeze is to dial up the stuff that will support job growth and innovation while dialing down the stuff that doesn't," Bernstein wrote. "Under our plan, some discretionary spending will go up; some will go down. That's a big difference from a hatchet." But some aren't entirely convinced that science funding will be spared the axe. "We are extremely concerned about the proposed freeze on non-security discretionary spending, particularly in light of the compelling evidence that an innovation-driven economy is the future," said linkurl:Mary Woolley,;http://www.researchamerica.org/mary_woolley president and CEO of science advocacy group Research!America. "We're looking to the President for national priority-setting that's consistent with that goal." The Federation of American Societies for Experimental Biology (FASEB), another science advocacy organization, is holding out hope that Obama's past statements on the importance of science and research in rebuilding the economy portend a reprieve for federal research funding agencies, such as the National Institutes of Health and the National Science Foundation. "We're hopeful that science is enough of a priority in the president's agenda that the scientific agencies we care about will not be included [in the freeze]," FASEB spokesperson Carrie Wolinetz told __The Scientist__. "It's something that we're waiting to hear more details about."
**__Related stories:__***linkurl:A windfall year at NIH;http://www.the-scientist.com/blog/display/56220/
[16th December 2009]*linkurl:2010 NIH budget bump;http://www.the-scientist.com/blog/display/56211/
[10th December 2009]*linkurl:NIH recovery grants top $5 billion;http://www.the-scientist.com/blog/display/56027/
[30th September 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas